200
Participants
Start Date
November 27, 2018
Primary Completion Date
January 31, 2028
Study Completion Date
March 31, 2028
Omalizumab
anti-ige injection
Placebo
placebo comparator arm, injection similar to active
Children's National Medical Center, Washington D.C.
Emory University, Atlanta
Cincinnati Children's Hospital Medical Center, Cincinnati
Indiana University/Riley Children's Hospital, Indianapolis
University of Wisconsin, Madison
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Washington University, St Louis
Texas Children's Hospital/Baylor College of Medicine, Houston
Childrens Hospital Colorado, Aurora
Phoenix Children's Hospital, Phoenix
Rady Children's Hospital - San Diego, San Diego
Connecticut Children's Hospital, Hartford
Boston Children's Hospital, Boston
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Boston Children's Hospital
OTHER